English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 5 October 2023, 08:52 HKT/SGT
Share:
    

Source: CorDx
CorDx to Launch New Global Brand, CuPet, in Singapore

SINGAPORE, Oct 5, 2023 - (ACN Newswire) - CorDx will take a revolutionary step in animal healthcare with the official global launch of CuPet at the 2023 Singapore Vet Show. CuPet aims to be customers' first choice in animal health, offering a one-stop solution for all diagnostic needs.

CuPet will showcase its innovative solutions at the Singapore Vet Show at booth D12 from October 13-14, 2023.

With an unwavering dedication to animal well-being, CuPet delivers accurate, intuitive, and affordable diagnostic test kits. Focused on efficiency and speed, CuPet diagnostic tests are designed for both veterinarians and pet owners. The brand prioritizes precise disease identification, ensuring quick and reliable results when every second counts. CuPet's comprehensive product range offers solutions for a variety of species and diseases, eliminating the need for multiple suppliers.

Developed through rigorous research, CuPet adheres to the highest scientific standards. The brand's product line includes 13 CE-marked test kits, employing advanced technologies such as colloidal gold and PCR. CuPet ensures user-friendly design, enabling both professionals and first-time pet owners to trust their intuitive solutions.

CuPet doesn't just provide products; it offers unparalleled customer support. From training to assistance, CuPet ensures that every user maximizes the utility and reliability of its products.

With a focus on affordability, CuPet challenges the market with competitive pricing without compromising on quality.

For More Information:

To view CuPet's product range or request a demo, visit en.cupet.com.

About CorDx :

Headquartered in the United States, CorDx is transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated supply chain, and manufacturing footprints across the United States and around the world. Through its product realization partnerships with leading pharmaceutical companies, CorDx develops, manufactures, and distributes diagnostics and related tools that empower users to monitor and improve their health. Its proprietary line of diagnostics solutions is recognized by families and medical professionals for their reliability, affordability, and rapid results.

CorDx, a CorDx Union company, is a biotechnology organization that delivers medical device solutions to healthcare industries and over a billion users in more than 170 countries.

Contact Information

Jessica Wills, Marketing Director, cupet@cordx.com, (678) 6802380



Topic: Press release summary
Source: CorDx

Sectors: Regional
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Luxury NEV Maker Seres Delivers Sustained Profitability and Strong Dividends  
Apr 22, 2026 15:31 HKT/SGT
NEC Receives Company of the Year recognition in Global Biometric Solutions from Frost & Sullivan  
Wednesday, April 22, 2026 1:46:00 PM
Everest Medicines Announces Positive First-in-Human Data for Personalized mRNA Cancer Vaccine EVM16 at AACR 2026  
Apr 22, 2026 13:41 HKT/SGT
MHIEC Completes Improvement of Core Equipment at Municipal Solid Waste Incineration Facility in Kagoshima City
  
Wednesday, April 22, 2026 10:13:00 AM
MHIEC Completes Improvement of Core Equipment at Municipal Solid Waste Incineration Facility in Sendai City  
Wednesday, April 22, 2026 10:03:00 AM
Seven HKTDC Lifestyle and Licensing mega events to open next week  
Apr 22, 2026 09:47 HKT/SGT
A new system to track material design processes  
Apr 22, 2026 03:00 HKT/SGT
Graid Technology Launches Agentic AI Storage Portfolio to Eliminate KV Cache Bottlenecks  
Apr 22, 2026 03:00 HKT/SGT
Genius Foundation's GENIUS Token Surges Following TGE, Briefly Tops $800 Million FDV  
Apr 21, 2026 22:46 HKT/SGT
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)  
Tuesday, April 21, 2026 7:52:00 PM
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575